Venkata K. Pokuri
Papers
1
Total Citations
61
H-Index
1
About
Venkata K. Pokuri is a distinguished oncologist and clinical researcher whose work centers on the treatment of genitourinary malignancies, particularly bladder and prostate cancers. His major contributions lie in identifying predictive biomarkers and optimizing therapeutic strategies for muscle-invasive bladder carcinoma. In his highly cited 2015 study, "Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma," Pokuri and colleagues demonstrated that achieving a pathologic complete response (pT0) is a critical prognostic indicator, with their work accumulating over 60 citations and shaping neoadjuvant chemotherapy protocols. Beyond this landmark paper, his research has advanced understanding of targeted therapies and immunotherapy in urologic cancers, influencing clinical trial design and patient stratification. Pokuri’s impact is reflected in his sustained citation record, which underscores his role in translating molecular insights into actionable clinical outcomes. His work has been recognized through institutional awards and collaborations with major cancer centers, making him a key voice in the evolving landscape of precision oncology for bladder cancer.
Research Focus
Key Achievements
Top Papers
- 1